Lahore, October 8, 2026: The Drug Regulatory Authority of Pakistan (DRAP) has sealed a manufacturing unit in Lahore for allegedly producing and packaging unregistered syringes without the required registration and licence.
According to a report by SAMAA TV, a large quantity of unregistered 3ml and 5ml syringes was recovered during the raid. The authorities also confiscated equipment and materials used in the manufacturing and packaging process.
DRAP Takes Action Against Unregistered Medical Products
Federal Drug Inspector Maaham Misbah, stationed in Lahore, conducted the raid alongside a DRAP team.
Officials said the unit was manufacturing and packaging syringes without the necessary regulatory approvals. The action was aimed at preventing the production and supply of counterfeit, substandard and unregistered medical products in the market.
Health Risks Associated with Unsafe Syringes
DRAP warned that the use of unsafe or substandard syringes can increase the risk of transmitting blood-borne infections, including hepatitis C and HIV, particularly when infection-control and safe injection practices are not followed.
The authority’s action highlights the importance of regulatory oversight in medical-device manufacturing and ensuring that healthcare products meet the required safety and quality standards.